二甲双胍联合氟伐他汀对初诊断血脂正常2型糖尿病血管内皮功能的影响(3)
[2] Yilmaz B,Sucak A,Kilic S,et al.Metformin regresses endometriotic implants in rats by improving implant levels of superoxidedismutase,vascular endothelial growth factor,tissue inhibitor of metalloproteinase-2,and matrix metalloproteinase-9[J].Am J Obstet Gynecol,2010,202(4):368.e1-8.
[3] Di Flaviani A,Picconi F,Di Stefano P,et al.Impact of glycemic andblood pressure variability on surrogate measures of cardiovascular outcomes in type 2 diabetic patients[J].Diabetes Care,2011,34(7):1605-1609.
[4] Celermajer D S,Sorensen K E,Gooch V M,et al.Non-invasivedetection of endothelialdysfunction in children and adults at risk of atherosclerosis[J].Lancet,1992,340(8828):1111-1115.
[5] Ross R.The pathogenesis of atherosclerosis: a perspective for the 1990s [J].Nature,1993,362(6423):801-809.
[6] Davignon J,Ganz P.Role of endothelialdysfunction in atherosclerosis[J].Circulation,2004,109(23Suppl1):27-32.
[7] Russo G,Leopold J A,Loscalzo J.Vasoactivesubstances:nitric oxide and endothelial dysfunction in atherosclerosis[J].Vascul Pharmacol,2002,38(5):259-269.
[8]鄔松林,朱刚艳,郝亚荣,等.二甲双胍对2型糖尿病血管内皮功能的影响[J].中华临床医师杂志,2013,7(10):4191-4195.
[9]孙志明.阿托伐他汀对冠脉粥样斑块和血管内皮功能的影响[J].中外医学研究,2016,14(35):1-3.
[10]姚华强,王芳,康震,等.氟伐他汀治疗糖尿病下肢血管病变近远期疗效观察[J].安徽医药,2016,20(5):983-984.
[11]刘清霞.氟伐他汀用于血脂异常治疗时对血管内皮功能的影响[J].中国医学工程,2011,19(6):91-93.
[12] Yoshida M,Sawada T,Ishii H,et al.Hmg-CoA reductase inhibitor modulates monocyte-endothelial cell interaction under physiological flow conditions in vitro:involvement of Rho GTPase-dependent mechanism[J].Arteriosclerosis,Thrombosis,and Vascular Biology,2001,21(7):1165-1171.
(收稿日期:2018-04-19), http://www.100md.com(张颖 李银萍)
[3] Di Flaviani A,Picconi F,Di Stefano P,et al.Impact of glycemic andblood pressure variability on surrogate measures of cardiovascular outcomes in type 2 diabetic patients[J].Diabetes Care,2011,34(7):1605-1609.
[4] Celermajer D S,Sorensen K E,Gooch V M,et al.Non-invasivedetection of endothelialdysfunction in children and adults at risk of atherosclerosis[J].Lancet,1992,340(8828):1111-1115.
[5] Ross R.The pathogenesis of atherosclerosis: a perspective for the 1990s [J].Nature,1993,362(6423):801-809.
[6] Davignon J,Ganz P.Role of endothelialdysfunction in atherosclerosis[J].Circulation,2004,109(23Suppl1):27-32.
[7] Russo G,Leopold J A,Loscalzo J.Vasoactivesubstances:nitric oxide and endothelial dysfunction in atherosclerosis[J].Vascul Pharmacol,2002,38(5):259-269.
[8]鄔松林,朱刚艳,郝亚荣,等.二甲双胍对2型糖尿病血管内皮功能的影响[J].中华临床医师杂志,2013,7(10):4191-4195.
[9]孙志明.阿托伐他汀对冠脉粥样斑块和血管内皮功能的影响[J].中外医学研究,2016,14(35):1-3.
[10]姚华强,王芳,康震,等.氟伐他汀治疗糖尿病下肢血管病变近远期疗效观察[J].安徽医药,2016,20(5):983-984.
[11]刘清霞.氟伐他汀用于血脂异常治疗时对血管内皮功能的影响[J].中国医学工程,2011,19(6):91-93.
[12] Yoshida M,Sawada T,Ishii H,et al.Hmg-CoA reductase inhibitor modulates monocyte-endothelial cell interaction under physiological flow conditions in vitro:involvement of Rho GTPase-dependent mechanism[J].Arteriosclerosis,Thrombosis,and Vascular Biology,2001,21(7):1165-1171.
(收稿日期:2018-04-19), http://www.100md.com(张颖 李银萍)